Literature DB >> 10334380

The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties.

D Rebouillat1, A G Hovanessian.   

Abstract

2',5'-Oligoadenylate synthetase (2',5'-OAS) was discovered and characterized as an interferon (IFN)-induced enzyme that in the presence of double-stranded (ds) RNA converts ATP into 2',5'-linked oligomers of adenosine with the general formula pppA(2'p'A)n, n > or = 1. The product is pppG2'p5'G when GTP is used as a substrate. Now, 20 years later, this activity is attributed to several well-characterized, homologous, and IFN-induced proteins in human cells. Three distinct forms of 2',5'-OAS exist, small, medium, and large, which contain 1, 2, and 3 OAS units, respectively, and are encoded by distinct genes clustered on the 2',5'-OAS locus on human chromosome 12. Recently, other IFN-induced proteins homologous to the OAS unit but devoid of the typical 2',5'-OAS catalytic activity have been described. These OAS-related proteins are encoded by a gene located at the proximity of the 2',5'-OAS locus. These findings illustrate the apparent structural and functional complexity of the human 2',5'-OAS family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334380     DOI: 10.1089/107999099313992

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  61 in total

1.  A monomeric GTPase-negative MxA mutant with antiviral activity.

Authors:  C Janzen; G Kochs; O Haller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Host genetic variability and West Nile virus susceptibility.

Authors:  Charles E Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

3.  Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.

Authors:  Anna A Kondratova; HyeonJoo Cheon; Beihua Dong; Elise G Holvey-Bates; Metis Hasipek; Irina Taran; Christina Gaughan; Babal K Jha; Robert H Silverman; George R Stark
Journal:  EMBO J       Date:  2020-04-23       Impact factor: 11.598

4.  Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.

Authors:  Junnan Zhang; Jie Shao; Xing Wu; Qunying Mao; Yiping Wang; Fan Gao; Wei Kong; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 6.  The response of mammalian cells to double-stranded RNA.

Authors:  Michael P Gantier; Bryan R G Williams
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-14       Impact factor: 7.638

7.  Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

Authors:  Xiaowen Su; Leland J Yee; KyungAh Im; Shannon L Rhodes; YongMing Tang; Xiaomei Tong; Charles Howell; Darmendra Ramcharran; Hugo R Rosen; Milton W Taylor; T Jake Liang; Huiying Yang
Journal:  J Hepatol       Date:  2008-05-20       Impact factor: 25.083

Review 8.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Toxoplasma gondii Inactivates Human Plasmacytoid Dendritic Cells by Functional Mimicry of IL-10.

Authors:  Piotr L Pierog; Yanlin Zhao; Sukhwinder Singh; Jihong Dai; George S Yap; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2017-11-27       Impact factor: 5.422

10.  Possible immunotherapeutic potentiation with D-fraction in prostate cancer cells.

Authors:  Paul Pyo; Brandon Louie; Srinivas Rajamahanty; Muhammad Choudhury; Sensuke Konno
Journal:  J Hematol Oncol       Date:  2008-12-04       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.